Sanleng Wan inhibits endometriosis progression by regulating sphingolipid metabolism via the S1P/S1PR1-Akt axis based on serum metabolomics and network pharmacology
This study investigates how Sanleng Wan regulates sphingolipid metabolism through the S1P/S1PR1-Akt axis to inhibit endometriosis progression, using serum metabolomics and network pharmacology.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (87)
- Activation of mammalian target of rapamycin in postmenopausal ovarian endometriosis via openalex
- [Clinical observation on treatment of endometriosis with principle of activating blood circulation to remove stasis]. via openalex
- Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial via openalex
- Endometriosis via openalex
- Endometriosis is associated with aberrant metabolite profiles in plasma via openalex
- Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology via openalex
- Gas Chromatography–Mass Spectrometry (GC–MS) Metabolites Analysis in Endometriosis Patients: A Prospective Observational Translational Study via openalex
- Identification of key modules and candidate genes associated with endometriosis based on transcriptome data via bioinformatics analysis via openalex
- Integration of 16 S rRNA gene sequencing, metabonomics and metagenome analysis to investigate the mechanism of Sparganium stoloniferum-Curcuma phaeocaulis in treating of endometriosis in rats via openalex
- Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics via openalex
- Metabolomics in endometriosis: challenges and perspectives for future studies via openalex
- Modular Characteristics and Mechanism of Action of Herbs for Endometriosis Treatment in Chinese Medicine: A Data Mining and Network Pharmacology–Based Identification via openalex
- PI3K/AKT signaling pathway associates with pyroptosis and inflammation in patients with endometriosis via openalex
- [Preventive and therapeutic effect of E-leng capsule on post-operation recurrence of ovarian endometriotic cysts and its influence on expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in eutopic and ectopic endometrium]. via openalex
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure via openalex
- Sphingosine 1-phosphate receptors are dysregulated in endometriosis: possible implication in transforming growth factor β–induced fibrosis via openalex
- Sphingosine 1-Phosphate (S1P) in the Peritoneal Fluid Skews M2 Macrophage and Contributes to the Development of Endometriosis via openalex
- State of the art, new treatment strategies, and emerging drugs for non-hormonal treatment of endometriosis: a systematic review of randomized control trials via openalex
- Tanshinone ⅡA participates in the treatment of endometriosis by regulating adhesion, invasion, angiogenesis and inhibition of PI3K/Akt/mTOR signaling pathway via openalex
- Therapeutic Roles of Statins in Gynecology and Obstetrics: The Current Evidence via openalex
- The role of fibrosis in endometriosis: a systematic review via openalex
- The Sphingosine 1-Phosphate Axis: an Emerging Therapeutic Opportunity for Endometriosis via openalex
- Transforming growth factor beta1 from endometriomas promotes fibrosis in surrounding ovarian tissues via Smad2/3 signaling† via openalex
- UPLC-Q-TOF/MS Based Plasma Metabolomics for Identification of Paeonol’s Metabolic Target in Endometriosis via openalex
- W3134885188 via openalex
- W3162053621 via openalex
- W3202037714 via openalex
- W3207428950 via openalex
- W3209083541 via openalex
- W3212454632 via openalex
- W3217346306 via openalex
- W4206806868 via openalex
- W4214754424 via openalex
- W4220981586 via openalex
- W4294225587 via openalex
- W4296519681 via openalex
- W4308522305 via openalex
- W4309195114 via openalex
- W4362519333 via openalex
- W4362660905 via openalex
- W4368358800 via openalex
- W4386030783 via openalex
- W4387643681 via openalex
- W4389051433 via openalex
- W4390099199 via openalex
- W4392858206 via openalex
- W4393316944 via openalex
- W4395112077 via openalex
- W4399221424 via openalex
- W4401106527 via openalex
- W4403733804 via openalex
- W4407275277 via openalex
- W4407902190 via openalex
- W4408811948 via openalex
- W6683305549 via openalex
- W6697579514 via openalex
- W6706597662 via openalex
- W6715413576 via openalex
- W6797377172 via openalex
- W6857286426 via openalex
- W6862880186 via openalex
- W6863281070 via openalex
- W569534875 via openalex
- W6874137092 via openalex
- W1516047133 via openalex
- W1967409305 via openalex
- W2100678718 via openalex
- W2101386379 via openalex
- W2110283222 via openalex
- W2123245589 via openalex
- W2132260833 via openalex
- W2146276289 via openalex
- W2156673559 via openalex
- W2156754327 via openalex
- W2412473590 via openalex
- W2443594880 via openalex
- W2468194934 via openalex
- W2897589411 via openalex
- W2917075888 via openalex
- W2946955396 via openalex
- W2962348518 via openalex
- W3007580834 via openalex
- W3037908215 via openalex
- W3048569636 via openalex
- W3099546248 via openalex
- W3111099601 via openalex
- W3114418359 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-26T00:31:20.206735+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00